3 results
Approved WMOPending
Primary:• The primary objective of the study is to demonstrate the efficacy of vorasidenib based on radiographic progression-free survival (PFS) per blinded independent review committee (BIRC) compared with placebo in subjects with residual or…
Approved WMOPending
To evaluate the clinical utility of the NaPi2b (67) Assay for use in the detection of NaPi2b in formalin-fixed, paraffin-embedded (FFPE) serous ovarian carcinoma tissue to determine patient eligibility for treatment with XMT-1536.
Approved WMORecruiting
To assess the effect of adding a tapering decision aid on a dynamic flare prediction model to disease-activity-guided dose optimisation (DGDO) on the incidence of flares and medication use.